Earnings calendar/PTGX
Protagonist Therapeutics, Inc. (PTGX)
Pre-earnings consensus targets and post-earnings beat/miss — standardized metrics from the earnings calendar. No narrative, no price targets.
Pre-earnings
Consensus targets for the next print, plus how the business has been running.
Next report
Nov 5, 2026
Consensus estimate row
EPS target
$2.19
Street estimate
Revenue target
$219.9M
Street estimate
Trailing EPS (avg 4Q)
$0.43
Beat rate last 4: 75%
Latest EPS YoY
+516.4%
vs 2025-08-06
Latest revenue YoY
+3749.2%
How results look so far
Trailing revenue (avg 4Q)
$92.4M
Printed quarters
EPS beat rate (4Q)
75%
Share of quarters that beat EPS est.
Post-earnings
Did the company hit the target? Actual vs estimate and surprise.
Last print
Aug 5, 2026
EPS beat
EPS actual / est
$2.29 / $2.27
+0.9%
Revenue actual / est
$213.5M / $212.0M
+0.7%
Result
Target reached
Based on EPS vs consensus
Earnings history
Estimate vs actual and surprise % by print date
| Date | EPS est | EPS act | EPS surprise | Rev est | Rev act | Rev surprise |
|---|---|---|---|---|---|---|
| 11/5/2026upcoming | $2.19 | Pending | — | $219.9M | Pending | — |
| 8/5/2026 | $2.27 | $2.29 | +0.9% | $212.0M | $213.5M | +0.7% |
| 5/6/2026 | $-0.65 | $0.06 | +109.2% | $12.2M | Pending | — |
| 5/5/2026 | $-0.65 | $0.05 | +107.7% | $11.7M | $56.4M | +381.7% |
| 2/27/2026upcoming | $-0.53 | Pending | — | $14.9M | Pending | — |
| 2/25/2026 | $-0.53 | $-0.69 | -30.2% | $8.7M | $7.4M | -14.9% |
| 2/20/2026upcoming | $-0.53 | Pending | — | $14.9M | Pending | — |
| 11/6/2025 | $-0.59 | $-0.62 | -5.1% | $14.9M | $4.7M | -68.4% |
| 8/6/2025 | $-0.53 | $-0.55 | -3.8% | $8.4M | $5.5M | -34.2% |
| 5/6/2025 | $-0.50 | $-0.19 | +62.0% | $6.6M | $28.3M | +332.0% |
| 2/21/2025 | $0.06 | $1.98 | +3200.0% | $81.0M | $170.6M | +110.6% |
| 11/7/2024 | $-0.59 | $-0.54 | +8.5% | $38.8M | $4.7M | -88.0% |
| 8/6/2024 | $-0.50 | $-0.50 | 0.0% | $8.0M | $4.2M | -47.9% |
| 5/7/2024 | $1.19 | $3.26 | +173.9% | $120.0M | $255.0M | +112.5% |
| 2/27/2024 | $0.03 | $0.44 | +1422.5% | $40.0M | $60.0M | +50.0% |
| 11/2/2023 | $-0.68 | $-0.58 | +14.7% | $38.3M | Pending | — |
| 8/3/2023 | $-0.65 | $-0.68 | -4.6% | $8.3M | Pending | — |
| 5/4/2023 | $-0.69 | $-0.67 | +2.9% | $2.0M | Pending | — |
| 3/15/2023 | $-0.67 | $-0.69 | -3.0% | $5.0M | Pending | — |
| 11/8/2022 | $-0.94 | $-0.64 | +31.9% | — | Pending | — |
| 8/4/2022 | $-0.99 | $-0.84 | +15.2% | $460,000 | $859,000 | +86.7% |
| 5/4/2022 | $-0.67 | $-0.43 | +35.8% | $21.2M | $25.7M | +21.4% |
| 2/28/2022 | $-0.79 | $-0.77 | +2.5% | $5.1M | $8.6M | +69.9% |
| 11/3/2021 | $-0.67 | $-0.70 | -4.5% | $2.0M | $10.3M | +406.7% |
| 8/4/2021 | $-0.62 | $-0.69 | -11.3% | $5.2M | $2.3M | -56.2% |
| 5/4/2021 | $-0.57 | $-0.54 | +5.3% | $3.1M | $6.2M | +98.4% |
| 3/10/2021 | $-0.47 | $-0.48 | -2.1% | — | $5.7M | — |
| 11/4/2020 | $-0.61 | $-0.21 | +65.6% | $9.4M | $13.1M | +38.9% |
| 8/6/2020 | $-0.57 | $-0.59 | -3.5% | $6.0M | $6.2M | +3.4% |
| 5/7/2020 | $-0.64 | $-0.72 | -12.5% | $3.5M | $3.6M | +4.3% |
| 3/10/2020 | $-0.64 | $-0.63 | +1.6% | $2.8M | $2.7M | -3.1% |
| 11/6/2019 | $-0.75 | $-0.61 | +18.7% | $4.8M | $4.1M | -14.1% |
| 8/7/2019 | $-0.27 | $-1.18 | -337.0% | $1.9M | $8.2M | +321.4% |
| 5/8/2019 | $-0.65 | $-0.58 | +10.8% | $1.6M | $1.6M | -1.7% |
| 3/12/2019 | $-0.42 | $-0.57 | -35.7% | $1.9M | $2.4M | +21.3% |
| 11/6/2018 | $-0.40 | $-0.38 | +5.0% | $6.0M | $6.1M | +2.7% |
| 8/7/2018 | $-0.30 | $-0.41 | -36.7% | $10.0M | $11.7M | +17.1% |
| 5/9/2018 | $-0.24 | $-0.36 | -50.0% | $8.7M | $10.8M | +24.1% |
| 3/7/2018 | $-0.36 | $-0.15 | +58.3% | $26.3M | $11.3M | -57.1% |
| 11/6/2017 | $-0.95 | $-0.29 | +69.5% | $21.5M | $8.8M | -59.2% |
| 8/8/2017 | $-0.92 | $-0.89 | +3.3% | — | Pending | — |
| 5/10/2017 | $-0.64 | $-0.84 | -31.2% | — | Pending | — |
| 3/7/2017 | $-0.52 | $-0.67 | -28.8% | — | Pending | — |
| 11/14/2016 | $-0.49 | $-0.87 | -77.6% | — | Pending | — |
| 9/15/2016 | $-0.77 | $-19.07 | -2376.6% | — | Pending | — |
| 8/12/2016 | — | $-2.00 | — | — | Pending | — |
| 12/31/2015 | — | $-0.93 | — | — | Pending | — |
| 9/30/2015 | — | $-0.59 | — | — | Pending | — |
| 6/30/2015 | — | $-0.55 | — | — | Pending | — |
| 3/31/2015 | — | $-0.46 | — | — | Pending | — |
Need PTGX data in your own agent or pipeline?
The earnings data on this page — report dates, consensus EPS/revenue estimates, actuals and surprise history — is also available programmatically through the EvidInvest MCP server & financial data API for Claude, Cursor, or any MCP client and HTTP pipeline.